Skip to content

Investigating the effect of ginger consumption on depressed patients

Investigating The effect of ginger consumption on depression, anxiety, sleep quality, cognitive function and metabolic, inflammatory and oxidative stress indices in depressed patients with overweight and obese

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240720062476N1
Enrollment
80
Registered
2024-07-30
Start date
2024-08-22
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression.

Interventions

Intervention group: 3 ginger supplements daily with a dose of 500 mg for 2 months.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Suffering from depression confirmed by a psychiatrist or psychologist based on the DSM-5 diagnostic criteria Suffering from overweight and obesity or, in fact, a BMI greater than or equal to 25 No routine consumption of ginger before or during the study

Exclusion criteria

Exclusion criteria: Menopause Pregnancy and breastfeeding Having an unstable or severe medical condition Follow a special diet Taking antioxidant or anti-inflammatory supplements during the last 3 months Having a serious mental disorder at the same time other than depression such as schizophrenia Allergy to ginger or its products

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: the beginning of the study, the end of the first month and the end of the study (the end of the second month). Method of measurement: Beck Depression Inventory-II (BDI-II).;Anxiety. Timepoint: the beginning of the study, the end of the first month and the end of the study (the end of the second month). Method of measurement: Beck Anxiety Inventory.;Sleep quality. Timepoint: the beginning of the study and the end of the study (the end of the second month). Method of measurement: Pittsburgh Sleep Quality Index.;Serum TNF-a, TOS and MDA indices. Timepoint: the beginning of the study and the end of the study (the end of the second month). Method of measurement: laboratory kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh akhlaghi

Shiraz University of Medical Sciences

msm.akhlaghi@gmail.com+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026